HPV Infections

Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology

A Phase 1 Study of PV-001 9-valent Human Papillomavirus(HPV) Vaccine

Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)

Tolerance and Effectiveness of C14 on HPV Infection

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Significance of the High-risk Hpv Viral Load

A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine

A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)

Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

A Phase I Study of Quadrivalent HPV Recombinant Vaccine

Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191

V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)

V501 Efficacy Study in Women Aged 18 to 26 (V501-027)

An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)

Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population